MedTrace Logo

Delta Shock Index in Predicting Massive Transfusion

NCT03786705 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 7957

Last updated 2018-12-26

No results posted yet for this study

Summary

Background: To determine the performance of delta shock index (ΔSI), a change in shock index (SI) upon arrival at the emergency room (ER) from that in the field in predicting the need for massive transfusion (MT) among adult trauma patients with stable blood pressure.

Methods: This study included data from all trauma patients aged 20 years and above who were hospitalized from January 1, 2009 to December 31, 2016 and was obtained from the registered trauma database of the hospital. Only patients who were transferred by emergency medical service from the accident site with a systolic blood pressure ≥ 90 mm Hg at the ER were included in this study. The 7,957 enrolled trauma patients were divided into 2 groups, those who had received blood transfusion ≥ 10 U (MT, n = 82) and those who had not (non-MT, n = 7,875). The odds ratios with 95% confidence intervals for associated patient conditions and the odds of need for MT by a given ΔSI were measured. The plot of specific receiver operating characteristic (ROC) curves was used to evaluate the best cutoff point that could predict the patient's probability of receiving MT.

Conditions

  • Trauma Patients Received Blood Transfusion ≥ 10 U
  • Trauma Patients Had Not Received Blood Transfusion ≥ 10 U

Interventions

OTHER

Massive transfusion

Trauma patients who had received blood transfusion≥10 U

OTHER

Non-Massive Transfusion

Trauma patients who had received blood transfusion\<10 U

Sponsors & Collaborators

  • Chang Gung Memorial Hospital

    lead OTHER

Eligibility

Min Age
20 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-06-05
Primary Completion
2018-12-20
Completion
2018-12-20

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03786705 on ClinicalTrials.gov